Autologous OC-L Vaccine and Ovarian Cancer

Clinical trial NCT02452775 · TERMINATED

Trial details

NCT number: NCT02452775
Sponsor: Abramson Cancer Center at Penn Medicine
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2015-05-01
Primary completion: 2018-05-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.